Divis Laboratories Ltd | Industry : (Pharmaceuticals) | |
---|---|---|
BSE Code : 532488 |
NSE Symbol : DIVISLAB |
P/E(TTM) : 82.16 |
ISIN Demat : INE361B01024 |
Div & Yield% : 0.58 |
EPS(TTM) : 62.57 |
Book Value(₹) : 507.94 |
Market Cap(₹Cr) : 136,472.09 |
Face Value(₹) : 2.00 |
Particulars | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|---|---|
Gross Sales | 2,063.00 | 2,259.00 | 1,808.00 | 1,868.00 | 1,730.00 | 1,908.00 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 2,063.00 | 2,259.00 | 1,808.00 | 1,868.00 | 1,730.00 | 1,908.00 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 79.00 | 79.00 | 94.00 | 85.00 | 80.00 | 66.00 |
Total Income | 2,142.00 | 2,338.00 | 1,902.00 | 1,953.00 | 1,810.00 | 1,974.00 |
Total Expenditure | 1,442.00 | 1,542.00 | 1,317.00 | 1,394.00 | 1,239.00 | 1,419.00 |
PBIDT | 700.00 | 796.00 | 585.00 | 559.00 | 571.00 | 555.00 |
Interest | 0.00 | 2.00 | 0.00 | 1.00 | 0.00 | 0.00 |
PBDT | 700.00 | 794.00 | 585.00 | 558.00 | 571.00 | 555.00 |
Depreciation | 97.00 | 94.00 | 95.00 | 94.00 | 93.00 | 87.00 |
Tax | 178.00 | 159.00 | 121.00 | 108.00 | 123.00 | 105.00 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -5.00 | 10.00 | 11.00 | 14.00 | 10.00 | 44.00 |
Reported Profit After Tax | 430.00 | 531.00 | 358.00 | 342.00 | 345.00 | 319.00 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 430.00 | 531.00 | 358.00 | 342.00 | 345.00 | 319.00 |
EPS (Unit Curr.) | 16.18 | 19.99 | 13.50 | 12.89 | 12.99 | 12.01 |
EPS (Adj) (Unit Curr.) | 16.18 | 19.99 | 13.50 | 12.89 | 12.99 | 12.01 |
Calculated EPS (Unit Curr.) | 16.23 | 20.04 | 13.51 | 12.91 | 13.02 | 12.04 |
Calculated EPS (Adj) (Unit Curr.) | 16.23 | 20.04 | 13.51 | 12.91 | 13.02 | 12.04 |
Calculated EPS (Ann.) (Unit Curr.) | 64.91 | 80.15 | 54.04 | 51.62 | 52.08 | 48.15 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 64.91 | 80.15 | 54.04 | 51.62 | 52.08 | 48.15 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 53.00 | 53.00 | 53.00 | 53.00 | 53.00 | 53.00 |
Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 33.93 | 35.24 | 32.36 | 29.93 | 33.01 | 29.09 |
PBDTM(%) | 33.93 | 35.15 | 32.36 | 29.87 | 33.01 | 29.09 |
PATM(%) | 20.84 | 23.51 | 19.80 | 18.31 | 19.94 | 16.72 |